Prediction of Death in Intracerebral Hemorrhage Patients After Minimally Invasive Surgery by Vital Signs and Blood Glucose

Abstract

This study examined the impact of vital signs and blood glucose levels on the long-term prognosis of intracerebral hemorrhage (ICH) patients treated with minimally invasive surgery (MIS). The patients diagnosed with ICH and treated with MIS within 24hours of admission at the ∗∗ Hospital between January 2020 and October 2021 were included. The relationship between a range of indicators, including vital signs, blood glucose levels, and patient mortality at discharge and 3 or 12months postdischarge were analyzed. A total of 195 consecutive patients were included, of which 16 patients passed away during hospitalization, 29 and 34 within 3 and 12months postdischarge, respectively. The multivariate analysis revealed that hospital death positively correlated with age ≥66.50years, fasting blood glucose ≥8.25mmol/L on the third day after MIS, systolic blood pressure ≥166.00mmHg on the third day, and heart rate ≥89.50 beats/min at discharge (area under the curve [AUC]= 0.927). Death at 3months positively correlated with male sex, blood glucose before dinner ≥8.15mmol/L on the second day after MIS, body temperature ≥36.95°C at discharge, and heart rate ≥89.50 beats/minute at discharge (AUC= 0.810). Death at 12months positively correlated with age ≥61.50years, body temperature ≥36.95°C at discharge, and heart rate ≥92.50 beats/min on the third day after MIS (AUC= 0.824). The prognosis of ICH patients after MIS is closely related to their vital signs and blood glucose levels at various stages of hospitalization.